Essential medicines and health products

Ye Lu

Ye Lu

Ye Lu, PhD
Professor, Fudan University, Shanghai

Professor Ye Lu is the director of Department of Health Economics of the School of Public Health, Fudan University. She received Bachelor degree of Law in Politics and Law from Shanghai Normal University in 1986. In 1997, she was awarded a Master of Economics degree in the School of Economics, University of Philippines. She received her PhD degree in Health Economics in Fudan University in 2008. She is a member of Advisory Committee for the center of drug pricing evaluation for the National Development and Reform Commission, She is also a member of the WHO Expert Advisory Panel on Drug Policies and Management until 2014, as well as being an executive committee member of the China Network of Training & Research in Health Economics and Financing, in the MOH. She has been a short-term Consultant on E-learning in China for the World Bank.

Her main research fields include the burden of disease, health reform and development, economic evaluation of health intervention program, drug pricing policy and national essential medicine policy, etc. She has been the principal investigator for a number of projects funded by the National Development and Reform Commission, the Ministry of Health and international organizations such as the World Health Organization, etc. Her studies are mostly focused on essential medicine policy and drug pricing issues in the past six years. Her monograph on essential medicines policy in China was published in 2009. She has worked in the Department of Essential Medicines and Pharmaceutical Policy, WHO as a visiting scholar where she worked on producing a chapter for the World Medicines Situation Report.

She has been a principal investigator in eight different studies:

  • Reforming Pharmaceutical Pricing and Reimbursement Policies in China (2003). The MERCK Company Foundation.
  • Emprical Study on Drug procurement bidding system in Shanghai (2005-2006). The MERCK Company Foundation.
  • The Survey of Medicine Prices, Availability and Affordability in Shanghai, China, using the WHO/HAI Methodology. (2006) WHO
  • Study on National Essential medicine Policy in China (2006) MOH
  • International Comparative Study on Patent Drug Pricing System. (2007) NDRC
  • Study on the Impact of Zero Mark-up of Medicine Dispensing in the Hospital in Shanghai. (2009-2010) Funded by Shanghai Municipal of Health Bureau
  • Study on Essential Medicine Policy Implementation in Community Health Center in China (2010) Funded by MOH, China
  • Study on the Feasibility of Essential Medicine Policy Implementation in Non-Government Running Community Health center in China (2010) Fund by MOH, China
Share